| News

Moderna driving forward production of vaccine from Basel

11.08.2020

Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss government has just signed a supply contract with the US company for 4.5 million doses of the vaccine.

Moderna is headquartered in Cambridge, Massachusetts in the USA. The biotech firm has now established a subsidiary in Basel, located close to Lonza, which is Moderna’s production partner. In establishing the new Moderna Switzerland GmbH, the company was “actively supported” by Basel Area Business & Innovation, as detailed by the investment and innovation promotion agency in a statement. The support ranged from answering questions related to setting up a company and work permits in view of the COVID-19 pandemic situation all the through to suggestions with regard to office space. The attractiveness of the biotech ecosystem in the Basel Area has been underlined following Moderna’s successful establishment of a new subsidiary in the region.

The new location will be managed by Nicolas Chornet, who has been appointed Senior Vice President International Manufacturing, Europe at Moderna. “Establishing a European presence for Moderna is key to delivering on our manufacturing commitments outside of the U.S., and an important aspect of our future growth plans”, explains Chornet, who previously spent ten years working for Novartis, in the press release.

The government has reached an agreement with Moderna for the delivery of 4.5 million doses of a coronavirus vaccine. Moderna’s development is focused on what is known as an mRNA vaccine. The mRNA is a type of messenger molecule that carries an instruction manual for the production of proteins and tells body cells how to produce a virus protein. As soon as the body starts to produce the protein, the immune system recognizes it as an antigen. After this, antibodies against the virus are produced, with the aim here being to prepare the body to fight the virus. A Phase 3 study focusing on this issue is currently being conducted in the USA.

“With Moderna’s vaccine candidate for COVID-19 now in Phase 3 clinical trials, we’re pleased to have Nicolas building our capabilities to deliver mRNA solutions to Europe and other countries outside the US, from Switzerland with our strategic partner Lonza”, comments Stéphane Bancel, CEO of Moderna, in the press release.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Botanikind settles in Basel
Basel Area Business & Innovation, Innovation, Invest

Botanikind settles in Basel

The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for...

Read More
Kinarus secures capital commitment of 57 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Kinarus secures capital commitment of 57 million Swiss francs

The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group...

Read More
Biotech startups from the Basel Area confirm leading position
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Biotech startups from the Basel Area confirm leading position

As part of the Top 100 Swiss Startup Awards 2021, the most promising startups in Switzerland are honored. These also...

Read More
T3 Pharma wins Swiss Economic Award
Basel Area Business & Innovation, Innovation, Invest

T3 Pharma wins Swiss Economic Award

T3 Pharma has won the Swiss Economic Award 2021. Switzerland’s most prestigious young entrepreneur prize is awarded by the Swiss...

Read More
Worg selects Basel Area for European headquarters
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Worg selects Basel Area for European headquarters

Worg Pharmaceuticals has opted to establish its European headquarters at the site Allschwil of the Switzerland Innovation Park Basel Area....

Read More
ten23 health settles in Basel
Basel Area Business & Innovation, Innovation, Invest

ten23 health settles in Basel

The life sciences cluster Rosental Mitte located in Basel is home to a new, globally active company called ten23 health....

Read More
1 2 3 48

Do you have a question? We'd like to hear from you.